Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Read More…
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Phone609-495-2495
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$801.84 million
Profitability
Miscellaneous
Employees1,485
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable
Innophos (NASDAQ:IPHS) Frequently Asked Questions
What is Innophos' stock symbol?
Innophos trades on the NASDAQ under the ticker symbol "IPHS."
How often does Innophos pay dividends? What is the dividend yield for Innophos?
Innophos announced a quarterly dividend on Tuesday, August 6th. Stockholders of record on Friday, August 23rd will be given a dividend of $0.48 per share on Friday, September 6th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.47%. The ex-dividend date is Thursday, August 22nd. View Innophos' Dividend History.
How were Innophos' earnings last quarter?
Innophos Holdings, Inc. (NASDAQ:IPHS) issued its earnings results on Tuesday, August, 6th. The specialty chemicals company reported $0.43 EPS for the quarter, topping the Zacks' consensus estimate of $0.37 by $0.06. The specialty chemicals company earned $185.04 million during the quarter, compared to analyst estimates of $196.55 million. Innophos had a return on equity of 12.35% and a net margin of 3.79%. Innophos's quarterly revenue was down 10.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.55 earnings per share. View Innophos' Earnings History.
When is Innophos' next earnings date?
What guidance has Innophos issued on next quarter's earnings?
Innophos issued an update on its FY 2019 earnings guidance on Tuesday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $745.86-753.88 million, compared to the consensus revenue estimate of $786.67 million.
What is the consensus analysts' recommendation for Innophos?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innophos in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innophos.
Has Innophos been receiving favorable news coverage?
Media stories about IPHS stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Innophos earned a media sentiment score of -2.4 on InfoTrie's scale. They also assigned news stories about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Innophos.
Who are some of Innophos' key competitors?
What other stocks do shareholders of Innophos own?
Who are Innophos' key executives?
Innophos' management team includes the folowing people:
- Dr. Kim Ann Mink, Chairman, CEO & Pres (Age 59)
- Mr. Hermanus Kieftenbeld, Sr. VP & CFO (Age 53)
- Ms. Sherry Duff, Sr. VP and Chief Marketing & Technology Officer (Age 51)
- Mr. Joshua Horenstein, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 42)
- Ms. Amy Hartzell, Sr. VP of Supply Chain & Purchasing (Age 43)
Who are Innophos' major shareholders?
Innophos' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Dalton Greiner Hartman Maher & Co. (0.58%) and State of Alaska Department of Revenue (0.08%). View Institutional Ownership Trends for Innophos.
Which institutional investors are buying Innophos stock?
How do I buy shares of Innophos?
Shares of IPHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Innophos' stock price today?
One share of IPHS stock can currently be purchased for approximately $35.08.
How big of a company is Innophos?
Innophos has a market capitalization of $690.76 million and generates $801.84 million in revenue each year. The specialty chemicals company earns $36.07 million in net income (profit) each year or $2.28 on an earnings per share basis. Innophos employs 1,485 workers across the globe.View Additional Information About Innophos.
What is Innophos' official website?
How can I contact Innophos?
Innophos' mailing address is 259 PROSPECT PLAINS ROAD, CRANBURY NJ, 08512. The specialty chemicals company can be reached via phone at 609-495-2495 or via email at [email protected]
MarketBeat Community Rating for Innophos (NASDAQ IPHS)
MarketBeat's community ratings are surveys of what our community members think about Innophos and other stocks. Vote "Outperform" if you believe IPHS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPHS will underperform the S&P 500 over the long term. You may vote once every thirty days.
